Elevated <scp>d</scp> -2-hydroxyglutarate during colitis drives progression to colorectal cancer
Jie Han(Baylor University Medical Center), Arianne L. Theiss(University of Colorado Anschutz Medical Campus), Rhonda F. Souza(Southwestern Medical Center), Beth N Cook(Baylor University Medical Center), K. Venuprasad(Baylor Medical Center at Garland), Kevin Turner(The University of Texas Southwestern Medical Center), Robert M. Genta(Southwestern Medical Center), Dakota N. Jackson(Baylor University Medical Center), Erland Arning(Baylor University Medical Center), Xuan Wang(Tulane University), Lawrence Sweetman(Baylor University Medical Center), Janette Holm(Baylor University Medical Center), Paula Ashcraft(Baylor University Medical Center)
Cited by 56
Related Papers
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
|Gastroenterology|2011|1.1k
Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline
|The American Journal of Gastroenterology|2022|476
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
|Molecular Cancer|2020|465
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
|Gastroenterology|2011|455